Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANAB Anaptysbio Inc

休市中 12-20 15:59:59 EST

14.55

-0.45

-3.00%

盘后14.55

+0.000.00%

17:30 EST

最高15.29	最低14.21	成交量158.86万
今开14.82	昨收15.00	日振幅7.23%
总市值4.43亿	流通市值2.89亿	总股本3,043万
成交额2,311万	换手率7.99%	流通股本1,988万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANAB","market":"US","secType":"STK","nameCN":"Anaptysbio Inc","latestPrice":14.55,"timestamp":1734728399999,"preClose":15,"halted":0,"volume":1588566,"hourTrading":{"tag":"盘后","latestPrice":14.55,"preClose":14.55,"latestTime":"17:30 EST","volume":286522,"amount":4168895.04,"timestamp":1734733811278},"delay":0,"floatShares":19881595,"shares":30428682,"eps":-6.043375,"marketStatus":"休市中","marketStatusCode":7,"change":-0.45,"latestTime":"12-20 15:59:59 EST","open":14.82,"high":15.29,"low":14.205,"amount":23110709.161428,"amplitude":0.072333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.043375,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1485406800000,"adjPreClose":15,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":15.79,"preClose":15,"latestTime":"09:25 EST","volume":1098,"amount":17330.279706,"timestamp":1734704705986},"postHourTrading":{"tag":"盘后","latestPrice":14.55,"preClose":14.55,"latestTime":"17:30 EST","volume":286522,"amount":4168895.04,"timestamp":1734733811278},"volumeRatio":2.6198362427986717,"optionData":{"bulkOrders":[{"symbol":"ANAB","call":false,"expireDate":1742529600000,"strike":"7.5","timestamp":1734717670900,"price":0.6499999761581421,"volume":1961,"amount":127465,"type":"-"},{"symbol":"ANAB","call":false,"expireDate":1742529600000,"strike":"22.5","timestamp":1734717670900,"price":10.699999809265137,"volume":1961,"amount":2098270,"type":"+"}]},"impliedVol":0.9769,"impliedVolPercentile":0.7778},"requestUrl":"/m/hq/s/ANAB","defaultTab":"news","newsList":[{"id":"2492428590","title":"Anaptysbio, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492428590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492428590?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:14","pubTimestamp":1734707697,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时14分，Anaptysbio, Inc.股票出现异动，股价快速跳水5.00%。截至发稿，该股报14.25美元/股，成交量6.8805万股，换手率0.23%，振幅6.47%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Humacyte, Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为2169.24%、102.81%、57.57%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Humacyte, Inc.，振幅分别为84.80%、50.00%、48.53%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220231457984cfd44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220231457984cfd44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB"],"gpt_icon":0},{"id":"2492468114","title":"美国研究综述-亚马逊、万事达卡、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2492468114","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492468114?lang=zh_cn&edition=full","pubTime":"2024-12-19 14:58","pubTimestamp":1734591497,"startTime":"0","endTime":"0","summary":"美国研究综述-亚马逊、万事达卡、特斯拉路透12月19日 - 华尔街证券分析师周四调整了对亚马逊、万事达卡和特斯拉等多家美国上市公司的评级和目标价。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4T3NK0JV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","TPR","ACHC","DSP","META","LU0820561909.HKD","NET","LU0672654240.SGD","MNKD","LU2456880835.USD","OKTA","S","TENB","LU1121112475.USD","LU0708994859.HKD","ZG","TGI","CRMD","FI","ASLE","HXL","LU0444971666.USD","USAW.SI","MA","IE00BJJMRY28.SGD","V","FTNT","ANAB","FHN","AMZN","WM","BROS","LU1989772923.USD","GIS","TKO","TSLA","TSYW.SI","PANW","WOR","VRNS","LU0096362180.USD","EAT","MNRO","AIN","UPWK"],"gpt_icon":1},{"id":"2492151717","title":"Anaptysbio, Inc.盘中异动 临近收盘股价大跌5.00%报15.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492151717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492151717?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:45","pubTimestamp":1734554733,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时45分，Anaptysbio, Inc.股票出现波动，股价大幅下挫5.00%。截至发稿，该股报15.19美元/股，成交量37.5578万股，换手率1.23%，振幅9.57%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为3.05%。其相关个股中，Polyrizon Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3232.84%、681.94%、351.46%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、151.68%、105.17%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044542ab82a3f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044542ab82a3f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2492196920","title":"Anaptysbio, Inc.盘中异动 大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492196920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492196920?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:52","pubTimestamp":1734447170,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时52分，Anaptysbio, Inc.股票出现波动，股价快速跳水5.05%。截至发稿，该股报15.81美元/股，成交量1.8282万股，换手率0.06%，振幅4.50%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Portage Biotech Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Marker Therapeutics, Inc.涨幅较大，Portage Biotech Inc.、Polyrizon Ltd.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为1593.99%、95.11%、21.51%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Portage Biotech Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为90.69%、46.46%、23.99%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217225250984c90c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217225250984c90c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2491375787","title":"Anaptysbio, Inc.盘中异动 早盘股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491375787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491375787?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:38","pubTimestamp":1734100695,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时38分，Anaptysbio, Inc.股票出现异动，股价大幅拉升5.23%。截至发稿，该股报15.81美元/股，成交量2.3938万股，换手率0.08%，振幅7.53%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Oculis Holding Ag C/Wts 06/03/2028 、Barinthus Biotherapeutics Plc涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为26.96%、22.10%、18.91%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、X4制药、Jupiter Neurosciences, Inc.，振幅分别为40.32%、24.46%、22.80%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322381595e9770c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322381595e9770c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB"],"gpt_icon":0},{"id":"2490162380","title":"Anaptysbio, Inc.盘中异动 大幅拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490162380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490162380?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:23","pubTimestamp":1734016989,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时23分，Anaptysbio, Inc.股票出现异动，股价大幅上涨5.22%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.76%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Palisade Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3174.90%、805.61%、70.50%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Palisade Bio, Inc.，振幅分别为75.86%、73.01%、63.57%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212232309a1e96a5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212232309a1e96a5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2490986266","title":"BUZZ-AnaptysBio 放弃湿疹药物开发后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2490986266","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490986266?lang=zh_cn&edition=full","pubTime":"2024-12-12 00:20","pubTimestamp":1733934056,"startTime":"0","endTime":"0","summary":"12月11日 -  ** AnaptysBio ANAB.O股价下跌多达 38.5%，跌至 14.20 美元的逾一年低点  ** 如果跌势不改，股价将创下2019年11月以来最差的一天 ** 该公司表示，由于未能达到一项中期试验的目标，它将停止湿疹药物ANB032的开发 。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4T3NC1B7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2490486504","title":"更新 2-AnaptysBio公司在中期试验失败后放弃湿疹药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2490486504","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490486504?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:15","pubTimestamp":1733930100,"startTime":"0","endTime":"0","summary":"     路透12月11日 - AnaptysBio  公司周三表示，由于治疗湿疹的实验性药物未能达到中期试验的目标，该公司将终止开发治疗湿疹的实验性药物，导致其股价下跌近40%。湿疹又称特应性皮炎，是一种慢性皮肤病，会引起炎症、发红和剧烈瘙痒。AnaptysBio 公司首席执行官丹尼尔-法加在一份声明中说，AnaptysBio 公司将专注于自身免疫产品组合的其他部分，其中包括治疗类风湿性关节炎和一种炎症性肠病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2490863367","title":"Anaptysbio, Inc.股价重挫33.09% 市值跌1.56亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490863367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490863367?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:31","pubTimestamp":1733927511,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时31分，Anaptysbio, Inc.股票出现异动，股价快速跳水33.09%。截至发稿，该股报15.45美元/股，成交量25.0235万股，换手率0.82%，振幅5.41%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为367.10%、106.42%、97.36%，振幅较大的相关个股有Candel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.，振幅分别为19.09%、18.15%、13.89%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223151ab6fca07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223151ab6fca07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CADL","RA","ANAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2490685734","title":"更新版 1-AnaptysBio公司在中期试验失败后放弃湿疹药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2490685734","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490685734?lang=zh_cn&edition=full","pubTime":"2024-12-11 21:48","pubTimestamp":1733924936,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (第2段增加股票，全文增加细节)    路透12月11日 - AnaptysBio   周三表示，由于未能达到中期试验的主要和次要目标，该公司将终止湿疹药物的开发。该公司股票在盘前交易中停牌。该药物 ANB032 没有达到主要目标，即湿疹严重程度指数比基线至少改善 75% 的患者比例。公司首席执行官丹尼尔-法加（Daniel Faga）在一份声明中说，公司将专注于自身免疫产品组合的其他部分，其中包括治疗类风湿性关节炎和一种炎症性肠病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2490852659","title":"AnaptysBio在中期试验失败后放弃湿疹药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2490852659","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490852659?lang=zh_cn&edition=full","pubTime":"2024-12-11 21:36","pubTimestamp":1733924174,"startTime":"0","endTime":"0","summary":"AnaptysBio在中期试验失败后放弃湿疹药物开发路透12月11日 - AnaptysBio ANAB.O公司周三表示，由于未能达到中期试验的主要和次要目标，该公司将停止湿疹药物的开发。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4S3NC0ZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB","BK4139"],"gpt_icon":0},{"id":"2490707865","title":"Anaptysbio, Inc.盘中异动 股价大跌5.00%报23.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490707865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490707865?lang=zh_cn&edition=full","pubTime":"2024-12-10 03:54","pubTimestamp":1733774063,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日03时54分，Anaptysbio, Inc.股票出现异动，股价大幅下挫5.00%。截至发稿，该股报23.57美元/股，成交量28.8886万股，换手率0.95%，振幅9.31%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121003542495e87508&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121003542495e87508&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB"],"gpt_icon":0},{"id":"2489263611","title":"Anaptysbio, Inc.盘中异动 急速拉升5.07%报24.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489263611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489263611?lang=zh_cn&edition=full","pubTime":"2024-12-07 04:01","pubTimestamp":1733515306,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日04时01分，Anaptysbio, Inc.股票出现异动，股价急速拉升5.07%。截至发稿，该股报24.86美元/股，成交量31.6901万股，换手率1.04%，振幅4.82%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207040146971c3219&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207040146971c3219&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2489465462","title":"Anaptysbio, Inc.盘中异动 股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489465462","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489465462?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:06","pubTimestamp":1733411209,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时06分，Anaptysbio, Inc.股票出现波动，股价快速拉升5.77%。截至发稿，该股报25.47美元/股，成交量8.5983万股，换手率0.28%，振幅5.17%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Molecular Templates, Inc.涨幅较大，Psyence Biomedical Ltd.、Molecular Templates, Inc.、Protara Therapeutics, Inc.较为活跃，换手率分别为2176.03%、454.77%、332.32%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为109.61%、88.14%、84.26%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205230649a1d6acbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205230649a1d6acbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"gpt_icon":0},{"id":"2488219083","title":"Anaptysbio, Inc.盘中异动 早盘股价大涨5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488219083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488219083?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:47","pubTimestamp":1733323640,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时47分，Anaptysbio, Inc.股票出现异动，股价大幅上涨5.68%。截至发稿，该股报23.25美元/股，成交量10.1458万股，换手率0.33%，振幅4.09%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Cyclerion Therapeutics, Inc.、Exicure, Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为1816.95%、209.42%、117.92%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Eterna Therapeutics Inc.、Heron Therapeutics, Inc.，振幅分别为237.89%、48.53%、34.75%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204224720971ba147&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204224720971ba147&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2488414789","title":"Anaptysbio, Inc.盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488414789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488414789?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:20","pubTimestamp":1733239248,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时20分，Anaptysbio, Inc.股票出现波动，股价大幅跳水5.05%。截至发稿，该股报23.15美元/股，成交量5.4348万股，换手率0.18%，振幅8.51%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Janux Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为139.32%、102.78%、97.01%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.，振幅分别为69.23%、51.13%、48.91%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203232048abf31225&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203232048abf31225&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2488867299","title":"Anaptysbio, Inc.盘中异动 大幅下跌7.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488867299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488867299?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:31","pubTimestamp":1733149908,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时31分，Anaptysbio, Inc.股票出现异动，股价急速下挫7.57%。截至发稿，该股报23.07美元/股，成交量2.0703万股，换手率0.07%，振幅2.70%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Cabaletta Bio, Inc.涨幅较大，Purple Biotech Ltd、Senti Biosciences, Inc.、Revelation Biosciences, Inc.较为活跃，换手率分别为666.84%、665.92%、202.77%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Renovaro Inc.，振幅分别为31.48%、16.99%、13.19%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223149abf000a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223149abf000a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB"],"gpt_icon":0},{"id":"2486500037","title":"Anaptysbio, Inc.盘中异动 股价大跌5.04%报22.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486500037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486500037?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:35","pubTimestamp":1732635314,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时35分，Anaptysbio, Inc.股票出现波动，股价急速下挫5.04%。截至发稿，该股报22.89美元/股，成交量8.0308万股，换手率0.26%，振幅3.88%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Poseida Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃，换手率分别为32.07%、20.84%、20.37%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.、Fate Therapeutics, Inc.，振幅分别为85.82%、42.94%、31.40%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126233514abe0dc49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126233514abe0dc49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0},{"id":"2486080400","title":"Anaptysbio, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486080400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486080400?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:37","pubTimestamp":1732545468,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时37分，Anaptysbio, Inc.股票出现波动，股价急速拉升5.03%。截至发稿，该股报23.39美元/股，成交量9140股，换手率0.03%，振幅2.47%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为90.25%、66.76%、41.55%，振幅较大的相关个股有Kodiak Sciences Inc、Werewolf Therapeutics, Inc.、Anixa Biosciences, Inc.，振幅分别为106.46%、105.79%、105.63%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223748971a85e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223748971a85e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB"],"gpt_icon":0},{"id":"2485216068","title":"Anaptysbio, Inc.盘中异动 下午盘股价大涨5.10%报22.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485216068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485216068?lang=zh_cn&edition=full","pubTime":"2024-11-23 04:24","pubTimestamp":1732307091,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日04时24分，Anaptysbio, Inc.股票出现波动，股价大幅上涨5.10%。截至发稿，该股报22.25美元/股，成交量17.4004万股，换手率0.57%，振幅6.57%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1930.76%、171.75%、106.94%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Virpax Pharmaceuticals, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为82.83%、77.68%、77.41%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112304245198e443a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112304245198e443a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anaptysbio.com","stockEarnings":[{"period":"1week","weight":-0.0667},{"period":"1month","weight":-0.2836},{"period":"3month","weight":-0.6219},{"period":"6month","weight":-0.3937},{"period":"1year","weight":-0.2663},{"period":"ytd","weight":-0.3207}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AnaptysBio, Inc.在特拉华成立于2005年11月。该公司是一家临床阶段的生物技术公司，专注于提供创新的免疫学疗法。该公司正在开发免疫细胞调节抗体，包括两种处于临床阶段开发阶段的针对自身免疫性和炎症性疾病的全资拥有的检查点激动剂：rosnilimab，该公司的PD-1激动剂，用于治疗中度至重度类风湿性关节炎（“RA”）的2b期试验和治疗中度至重度溃疡性结肠炎（“UC”）的2期试验；以及ANB032，该公司的BTLA激动剂，用于治疗中度至重度特应性皮炎（“AD”）的2b期试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.00144},{"month":2,"riseRate":0.875,"avgChangeRate":0.0982},{"month":3,"riseRate":0.25,"avgChangeRate":-0.083331},{"month":4,"riseRate":0.375,"avgChangeRate":0.003799},{"month":5,"riseRate":0.375,"avgChangeRate":-0.031718},{"month":6,"riseRate":0.625,"avgChangeRate":0.007623},{"month":7,"riseRate":0.5,"avgChangeRate":0.019018},{"month":8,"riseRate":0.625,"avgChangeRate":0.039779},{"month":9,"riseRate":0.5,"avgChangeRate":0.004586},{"month":10,"riseRate":0.625,"avgChangeRate":0.20142},{"month":11,"riseRate":0.25,"avgChangeRate":-0.066751},{"month":12,"riseRate":0.625,"avgChangeRate":0.048186}],"exchange":"NASDAQ","name":"Anaptysbio Inc","nameEN":"Anaptysbio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anaptysbio Inc(ANAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anaptysbio Inc,ANAB,Anaptysbio Inc股票,Anaptysbio Inc股票老虎,Anaptysbio Inc股票老虎国际,Anaptysbio Inc行情,Anaptysbio Inc股票行情,Anaptysbio Inc股价,Anaptysbio Inc股市,Anaptysbio Inc股票价格,Anaptysbio Inc股票交易,Anaptysbio Inc股票购买,Anaptysbio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anaptysbio Inc(ANAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}